• 1. Synthesis of aza and carbocyclic β-carbolines for the treatment of alcohol abuse. Regiospecific solution to the problem of 3,6-disubstituted β- and aza-β-carboline specificity
  V. V. N. Phani Babu Tiruveedhula,Kashi Reddy Methuku,Jeffrey R. Deschamps,James M. Cook Org. Biomol. Chem. 2015 13 10705
• 2. Flexible energy generation and storage devices: focus on key role of heterocyclic solid-state organic ionic conductors
  Jayraj V. Vaghasiya,Carmen C. Mayorga-Martinez,Martin Pumera Chem. Soc. Rev. 2020 49 7819
• 3. Polyhalogenoaromatic compounds. Part 46. Circumstantial evidence for the intermediacy of radical anions during the reaction of magnesium with ω-bromoalkoxypolychloro-arenes and -heteroarenes
  Basil J. Wakefield,Jeffrey P. Whitten,Paul S. Farley J. Chem. Soc. Perkin Trans. 1 1982 93
• 4. Organic chemistry
  J. Chem. Soc. Abstr. 1915 108 i637
• 5. Aza-analogues of pteridine. Part II. The novel use of silver oxide in transetherification of alkoxy-1,2,4,6,8-penta-azanaphthalenes, alkoxynitropyrimidines, and related systems
  D. J. Brown,T. Sugimoto J. Chem. Soc. C 1970 2661

Recent Advances in the Study of 2-propoxy-Pyridine (CAS: 101870-22-8) and Its Applications in Chemical Biology and Medicine

The compound 2-propoxy-Pyridine (CAS: 101870-22-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This research briefing aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential therapeutic uses. The discussion is based on recent peer-reviewed publications, patents, and industry reports, ensuring the accuracy and relevance of the information presented.

Recent studies have highlighted the role of 2-propoxy-Pyridine as a key intermediate in the synthesis of novel bioactive molecules. Its unique chemical structure, characterized by the presence of a pyridine ring and a propoxy side chain, allows for diverse modifications, making it a valuable scaffold in medicinal chemistry. Researchers have successfully utilized this compound to develop inhibitors targeting various enzymes and receptors implicated in diseases such as cancer, inflammation, and infectious diseases. The compound's ability to modulate biological pathways has been demonstrated in both in vitro and in vivo models, underscoring its potential as a therapeutic agent.

One of the most notable advancements in the study of 2-propoxy-Pyridine is its application in the development of kinase inhibitors. Kinases play a critical role in cell signaling and are often dysregulated in cancer. Recent research has shown that derivatives of 2-propoxy-Pyridine exhibit potent inhibitory activity against specific kinases, such as EGFR and BRAF, which are commonly mutated in various cancers. These findings have paved the way for the design of next-generation kinase inhibitors with improved selectivity and reduced side effects. Additionally, the compound's favorable pharmacokinetic properties, such as good oral bioavailability and metabolic stability, further enhance its appeal as a drug candidate.

Beyond its role in oncology, 2-propoxy-Pyridine has also been investigated for its anti-inflammatory and antimicrobial properties. Studies have demonstrated that certain derivatives of this compound can effectively suppress the production of pro-inflammatory cytokines, making them potential candidates for treating chronic inflammatory conditions like rheumatoid arthritis. Furthermore, its antimicrobial activity against drug-resistant bacterial strains has been reported, suggesting its utility in addressing the growing challenge of antibiotic resistance. These multifaceted applications highlight the compound's broad therapeutic potential.

In conclusion, the recent research on 2-propoxy-Pyridine (CAS: 101870-22-8) underscores its significance as a versatile scaffold in drug discovery. Its ability to serve as a building block for diverse bioactive molecules, coupled with its promising biological activities, positions it as a valuable tool in the development of novel therapeutics. Future studies should focus on optimizing its derivatives for enhanced efficacy and safety, as well as exploring its potential in other therapeutic areas. The continued investigation of this compound is expected to yield further breakthroughs in chemical biology and medicine.

• 27361-16-6(2-Butoxypyridine)
• 835596-19-5(Pyridine, 2-(3-butynyloxy)-)
• 16096-13-2(2-Isopropoxypyridine)
• 70289-27-9(2-(octyloxy)pyridine)
• 56446-65-2(Pyridine, 2,2'-[1,2-ethanediylbis(oxy)]bis-)
• 56446-64-1(2-(pyridin-2-yloxy)ethan-1-ol)
• 821806-12-6(1,2-Propanediol, 3-(2-pyridinyloxy)-, (2R)-)
• 14529-53-4(2-Ethoxypyridine)
• 408338-35-2(Propanenitrile,3-(2-pyridinyloxy)-)
• 204977-88-8(Pyridine,2-(2-methoxyethoxy)-)